PropertyValue
?:abstract
  • Abstract The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID-19 However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections
is ?:annotates of
?:creator
?:journal
  • Clinical_Case_Reports
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Treatment of cytokine storm syndrome with IL-1 receptor antagonist anakinra in a patient with ARDS caused by COVID-19 infection: A case report
?:type
?:who_covidence_id
  • #757781
?:year
  • 2020

Metadata

Anon_0  
expand all